RESEARCH TRIANGLE PARK, N.C., April 14, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (NASDAQ: TLCR) will issue its first quarter earnings release after the market closes on April 27, 2011. Due to the pending merger with Grifols, S.A., Talecris will not be hosting a conference call to discuss its first quarter results.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.

SOURCE Talecris Biotherapeutics, Inc.

Copyright 2011 PR Newswire

Talecris Biotherapeutics Holdings Corp. (MM) (NASDAQ:TLCR)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Talecris Biotherapeutics Holdings Corp. (MM).
Talecris Biotherapeutics Holdings Corp. (MM) (NASDAQ:TLCR)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Talecris Biotherapeutics Holdings Corp. (MM).